Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
TOP STORIES — Diabetes News and Research
Childhood Cardiovascular Risk Factors Can Predict Adult-Onset Diabetes
Are Women with Diabetes at Increased Risk of Repeated Heart Failure?
Phase 3 Comparison Trial: GLP-1 vs DPP-4
MOST POPULAR ARTICLES OF THE MONTH
#1 Intermittent Fasting Beneficial for Weight Loss and Glycemic Control
#2 Updated Consensus Report on Diabetic Nutrition Therapy
#3 Ketogenic Diet for Obesity and Diabetes: Do the Benefits Outweigh the Risks?
Editor's Note
Although, for most of us reading this week’s newsletter, the idea of giving a GLP-1 mimetic in a once a week shot presents no problem, there are many patients who could never tolerate even one shot per year. This can present a problem and cause prescribers to choose other medications.
Now that we have an oral GLP-1 medication it may be possible to help these patients, but how does it stack up against the results from other oral medications? Adam Chalela B.S., PharmD Candidate, USF College of Pharmacy, has a great comparison of the effects of this novel oral medication with a DPP4 inhibitor.
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
After starting a new medication (gabapentin) for his neuropathy, a patient of mine gained 30lbs and presented with peripheral edema without symptoms.
TOP STORIES — Diabetes News and Research
While cardiovascular risk factors are used to predict risk for clinical outcomes and base therapies, it may be a fluctuation in such risk factor measurements that has the most impact.
Heart failure is a common macrovascular complication that may occur in patients with diabetes, but what gender is more prone to have continuous hospitalization for heart failure problems?
A recent study demonstrates the efficacy of a new, once daily oral option for patients with type 2 diabetes already on metformin.
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.